Literature DB >> 1593050

DDD pacing mode survival in patients with a dual-chamber pacemaker.

J N Gross1, S Moser, Z M Benedek, C Andrews, S Furman.   

Abstract

Dual-chamber (DDD) pacing mode survival was assessed by reviewing 486 consecutive initial transvenous DDD pacemaker implantations between December 1981 and December 1988 inclusive, with a mean follow-up time of 33 months. The patients' mean age was 71.4 years and 55% were male; 38% had dominant sinoatrial and 62% had dominant atrioventricular (AV) node disease. Nineteen patients (4%) underwent secondary operative intervention for lead dislodgement (n = 11), lead or pulse generator malfunction (n = 6) or infection (n = 2). During follow-up, 87 patients (18%) had their device permanently reprogrammed out of the DDD mode and 10 others (2%) required temporary reprogramming out of this mode; 12 patients who required device reprogramming were managed in other dual-chamber or atrial pacing modes. Reasons for reprogramming included atrial fibrillation (n = 48; 10%); loss of atrial sensing (n = 26; 5%); recurrent "endless loop" tachycardia (n = 5; 1%); lead dislodgement without repositioning (n = 4; 1%); pulse generator malfunction (n = 1; 1%) and other (n = 5; 1%). The occurrence of atrial fibrillation was associated with dominant sinoatrial disease and a prior history of atrial fibrillation; 19% of atrial sensing loss was attributable to early or faulty pacemaker technology. The DDD mode survival rate at 1, 2, 3, 4 and 5 years was, respectively, 90%, 88%, 84%, 79% and 78%.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1593050     DOI: 10.1016/0735-1097(92)90615-t

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

1.  [Not Available].

Authors:  M J Jakob; N Treese; G F Rettig-Stürmer
Journal:  Herzschrittmacherther Elektrophysiol       Date:  1998-02

2.  Who needs dual chamber pacing?

Authors:  M C Petch
Journal:  BMJ       Date:  1993-07-24

Review 3.  Permanent pacemakers and the elderly: concerns, costs and benefits.

Authors:  J M McComb; R S Bexton
Journal:  Br Heart J       Date:  1995-07

4.  Development of sinus node disease in patients with AV block: implications for single lead VDD pacing.

Authors:  U K Wiegand; F Bode; R Schneider; A Brandes; H Haase; H A Katus; J Potratz
Journal:  Heart       Date:  1999-06       Impact factor: 5.994

5.  Prevalence of atrial fibrillation and stroke in paced patients without prior atrial fibrillation: a prospective study.

Authors:  A V Mattioli; E T Castellani; D Vivoli; F A Sgura; G Mattioli
Journal:  Clin Cardiol       Date:  1998-02       Impact factor: 2.882

6.  Predictors of atrial rhythm after atrioventricular node ablation for the treatment of paroxysmal atrial arrhythmias.

Authors:  G M Gribbin; J P Bourke; J M McComb
Journal:  Heart       Date:  1998-06       Impact factor: 5.994

Review 7.  [Pacemaker therapy in patients with atrial fibrillation].

Authors:  A Schuchert; T Meinertz
Journal:  Herz       Date:  1998-06       Impact factor: 1.443

8.  Dual chamber pacing: how many patients remain in DDD mode over the long term?

Authors:  B Ibrahim; J E Sanderson; B Wright; R Palmer
Journal:  Br Heart J       Date:  1995-07

9.  Combining current of injury and P-wave sensing optimized right atrial active-fixation leads implantation.

Authors:  Meng-Rong Chen; Fei-Long Zhang; Wei-Wei Wang; Xue-Hai Chen; Jian-Hua Chen; Liang-Long Chen
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.